Sangamo Therapeutics, Inc. (SGMO)

NASDAQ: SGMO · Real-Time Price · USD

0.2700

-0.0051 (-1.85%)

At close: Apr 16, 2026, 4:00 PM EDT

0.2772

+0.0072 (2.67%)

After-hours: Apr 16, 2026, 7:38 PM EDT

Sangamo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	20.95	41.92	45.2	100.44	178.87
Short-Term Investments	-	-	35.8	177.19	197.68
Cash & Short-Term Investments	20.95	41.92	81	277.63	376.55
Cash Growth	-50.03%	-48.25%	-70.82%	-26.27%	-41.30%
Total Trade Receivables	10.51	4.6	4.07	4.47	6.36
Other Current Assets	4.37	5.18	9.26	18.22	15.86
Total Current Assets	35.83	51.69	94.33	300.33	398.77
Net Property, Plant & Equipment	14.11	34.76	52.87	125.53	124.7
Other Intangible Assets	-	-	-	50.73	53.76
Goodwill	-	-	-	37.55	39.7
Long-Term Investments	-	-	-	29.85	88.17
Other Long-Term Assets	9.81	15.19	18.13	18.52	16.82
Total Assets	59.75	101.64	165.32	562.51	721.92
Accounts Payable	14.44	15.49	15.26	22.42	9.76
Accrued Expenses	27.13	22.76	32.47	37.51	32.42
Unearned Revenue	0.9	7.56	-	51.78	85.71
Total Current Liabilities	42.47	45.81	47.73	111.71	127.89
Long-Term Leases	25.09	26.25	33.52	38.99	44.06
Other Long-Term Liabilities	6.45	6.81	1.19	116.85	174.64
Total Long-Term Liabilities	31.55	33.06	34.7	155.84	218.69
Total Liabilities	74.01	78.87	82.43	267.55	346.58
Common Stock	3.51	2.13	1.78	1.67	1.46
Additional Paid-in Capital	1,611	1,532	1,492	1,450	1,334
Accumulated Other Comprehensive Income	-1.46	-7.53	-4.6	-8.4	-3.99
Retained Earnings	-1,627	-1,504	-1,406	-1,149	-956.27
Total Common Shareholders' Equity	-14.27	22.77	82.89	294.96	375.34
Shareholders' Equity	-14.27	22.77	82.89	294.96	375.34
Total Liabilities & Equity	59.75	101.64	165.32	562.51	721.92
Total Debt	25.09	26.25	33.52	38.99	44.06
Net Cash (Debt)	-4.15	15.67	47.49	238.65	332.49
Net Cash Growth	-	-67.01%	-80.10%	-28.23%	-44.86%
Net Cash Per Share	-0.01	0.08	0.27	1.55	2.30
Book Value	-14.27	22.77	82.89	294.96	375.34
Book Value Per Share	-0.05	0.11	0.48	1.91	2.60
Tangible Book Value	-14.27	22.77	82.89	206.68	281.88
Tangible Book Value Per Share	-0.05	0.11	0.48	1.34	1.95

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q